CLINICAL RESEARCH: CORONARY ARTERY DISEASE
The Effects of Plasma Insulin and Glucose on Myocardial Blood Flow in Patients With Type 1 Diabetes Mellitus
Muthayyah Srinivasan, MBBS, MS*,
Pilar Herrero, MS ,
Janet B. McGill, MD ,
Jasper Bennik, MD,
Bastiaan Heere, MD,
Donna Lesniak, RN,
Victor G. Davila-Roman, MD* and
Robert J. Gropler, MD*,,*
* Cardiovascular Division, Department of Medicine, Edward Mallinckrodt Institute of Radiology, St. Louis, Missouri.
Division of Radiological Sciences, Edward Mallinckrodt Institute of Radiology, St. Louis, Missouri.
Division of Endocrinology and Metabolism, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
Manuscript received September 29, 2004;
revised manuscript received February 4, 2005,
accepted March 10, 2005.
* Reprint requests and correspondence: Dr. Robert J. Gropler, Cardiovascular Imaging Laboratory, Mallinckrodt Institute of Radiology, 510 South Kingshighway Boulevard, St. Louis, Missouri 63110. (Email: groplerr{at}mir.wustl.edu).
OBJECTIVES: The objective of this study was to determine the impact of insulin and glucose on myocardial vasodilator function in patients with type 1 diabetes mellitus (T1DM).
BACKGROUND: The relative importance of plasma insulin and glucose levels on the abnormal vasodilator function observed in T1DM is unknown.
METHODS: Twenty T1DM patients underwent positron emission tomography studies to measure myocardial blood flow (MBF) (in ml/g/min) at rest (MBFr) and during adenosine (MBFa), both under baseline metabolic conditions and then during either hyperinsulinemic-euglycemic clamp (HE) (n = 10; 40 ± 9 years, 8 female subjects, hemoglobin A1c [HbA1c] 7.8 ± 1.1%) or hyperinsulinemic-hyperglycemic clamp (HH) (n = 10; 44 ± 12 years, 8 female subjects, hemoglobin A1c 7.7 ± 0.6%).
RESULTS: Both groups showed similar MBFr and MBFa under baseline metabolic conditions (p = NS). Compared with baseline conditions, MBFr increased in the HH group (p < 0.005), whereas it did not change in the HE group. Compared with baseline conditions, MBFa decreased in the HH group (p < 0.05) but did not change in the HE group. Myocardial perfusion reserve (MPR) (MBFa /MBFr) was similar between the HE and HH groups at baseline (p = NS). During clamp, MPR tended to decrease in the HH group (p < 0.1) but did not change in the HE group (p = NS) when compared with baseline conditions. However, during the clamp MPR was significantly lower in the HH group when compared with the HE group (p < 0.0001).
CONCLUSIONS: In the short term, hyperglycemia has a deleterious effect on myocardial vasodilator function, which outweighs the beneficial effect of hyperinsulinemia.
|
Abbreviations and Acronyms
| | HbA1c = hemoglobin A | | HE = hyperinsulinemic-euglycemic clamp | | HH = hyperinsulinemic-hyperglycemic clamp | | MBF = myocardial blood flow | | MBFa = myocardial blood flow during adenosine | | MBFr = myocardial blood flow at rest | | MPR = myocardial perfusion reserve | | RPP = rate-pressure product | | T1DM = type 1 diabetes mellitus | | T2DM = type 2 diabetes mellitus |
|
Related Article
-
Glucose for the Heart: Too Much of a Good Thing?
- Heinrich Taegtmeyer
J. Am. Coll. Cardiol. 2005 46: 49-50.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
V. Sharma, P. Dhillon, R. Wambolt, H. Parsons, R. Brownsey, M. F. Allard, and J. H. McNeill
Metoprolol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat
Am J Physiol Heart Circ Physiol,
April 1, 2008;
294(4):
H1609 - H1620.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Chaudhuri, M. Miller, R. Nesto, N. Rosenberg, and P. Dandona
Targeting Glucose in Acute Myocardial Infarction: Has glucose, insulin, and potassium infusion missed the target?
Diabetes Care,
December 1, 2007;
30(12):
3026 - 3028.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Cortigiani, F. Rigo, S. Gherardi, R. Sicari, M. Galderisi, F. Bovenzi, and E. Picano
Additional Prognostic Value of Coronary Flow Reserve in Diabetic and Nondiabetic Patients With Negative Dipyridamole Stress Echocardiography by Wall Motion Criteria
J. Am. Coll. Cardiol.,
October 2, 2007;
50(14):
1354 - 1361.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. W. Zarich and R. W. Nesto
Implications and Treatment of Acute Hyperglycemia in the Setting of Acute Myocardial Infarction
Circulation,
May 8, 2007;
115(18):
e436 - e439.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. d. l. Fuentes, A. L. Brown, S. J. Mathews, A. D. Waggoner, P. F. Soto, R. J. Gropler, and V. G. Davila-Roman
Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass
Eur. Heart J.,
March 1, 2007;
28(5):
553 - 559.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. M. Madsen, H. M. Sondergaard, M. Bottcher, N. H. Buus, O. Schmitz, H. E. Botker, and T. T. Nielsen
Impact of Type 2 Diabetes on Nitric Oxide and Adrenergic Modulation of Myocardial Perfusion
Diabetes,
February 1, 2007;
56(2):
468 - 475.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Galderisi
Diastolic Dysfunction and Diabetic Cardiomyopathy: Evaluation by Doppler Echocardiography
J. Am. Coll. Cardiol.,
October 17, 2006;
48(8):
1548 - 1551.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Taegtmeyer
Glucose for the Heart: Too Much of a Good Thing?
J. Am. Coll. Cardiol.,
July 5, 2005;
46(1):
49 - 50.
[Full Text]
[PDF]
|
|
|
|
